Androgen associated hepatocellular carcinoma with an aggressive course.
The hepatocellular carcinomas that develop in patients treated with androgens have previously been associated with a benign clinical outcome. We describe a man who developed a hepatocellular carcinoma after 24 years of androgen treatment, whose tumour initially showed partial regression after withdrawal of androgens but subsequently pursued an aggressive and fatal course.
Gleeson
D
D
Department of Gastroenterology, Royal Infirmary, Manchester.
Newbould
M J
MJ
Taylor
P
P
McMahon
R F
RF
Leahy
B C
BC
Warnes
T W
TW
D006528:Carcinoma, Hepatocellular / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008134:Long-Term Care; D008297:Male; D008777:Methyltestosterone / Q000009:adverse effects*; D008875:Middle Aged
D008777:Methyltestosterone